by Diego Guenot | Feb 1, 2024 | AMD
Breaking news: CLINICAL TRIAL VALIDATES CUTTING-EDGE ANALYSIS FOR AMD! Age-related Macular degeneration (AMD) is the leading cause of blindness in the western world with 200 million people affected and causing 4 million cases of Blindness. Treatments exist but are...
by Diego Guenot | Jan 26, 2024 | Uncategorized
What is the potential of hyperspectral retinal imaging? In 2016, Google has published a deep learning algorithm to detect diabetic retinopathy (DR) called Automated Retinal Disease Assessment (ARDA)¹. The model trained on more than 100,000 retinal images was able to...
by Diego Guenot | Jan 26, 2024 | Uncategorized
Webinar’s Q&A Mantis Photonics conducted a webinar on January 11th 2024, aiming to introduce the company to potential investors. Following the meeting, a question and answer (Q&A) session occurred, you can find the transcription directly below. For...
by Diego Guenot | Jan 26, 2024 | Uncategorized
Mantis Photonics’ crowdfunding campaign gaining momentum Mantis Photonics, a Swedish medical technology company developing non-invasive and portable hyperspectral imaging solutions for early disease detection, has surpassed the 50% funding milestone in its...
